Back |
home / stock / bgne / bgne message board
Subject | By | Source | When |
---|---|---|---|
BGNE presently $269.42 +$6.19 (+2.35%) | MiamiGent | investorshub | 01/13/2023 7:42:57 PM |
znewcar1: $BGNE 20% v854K c151.3 f103,7M H155.74 ML124.46 | znewcar1 | investorshangout | 10/12/2022 8:50:54 PM |
Looking good! | luke424 | investorshub | 05/05/2022 6:43:44 PM |
Last year, I think Bernstein had price target | luke424 | investorshub | 04/01/2022 1:44:56 PM |
Great, Old timers will soon begin loading up | luke424 | investorshub | 04/01/2022 1:27:07 PM |
Made a nice bet. Bought yesterday. https://www.cnbc.com/2022/04/01/china-securit | luke424 | investorshub | 04/01/2022 1:20:06 PM |
$AMGN to acquire 20% stake in BGNE; joint | north40000 | investorshub | 11/04/2019 1:57:31 AM |
Market sentiment is not good for pharmaceutical company, | StockLearner2011 | investorshub | 03/26/2019 6:46:50 PM |
Hope no one will jump down the window | StockLearner2011 | investorshub | 03/26/2019 4:20:57 PM |
Buy out is not going to happen that | StockLearner2011 | investorshub | 03/22/2019 7:24:38 PM |
Looking at insider transactions, the total shares bought | StockLearner2011 | investorshub | 03/22/2019 7:22:16 PM |
Howard Liang could have made 40000 X $22 | StockLearner2011 | investorshub | 03/22/2018 12:03:58 PM |
https://www.gurufocus.com/news/648598/beigene-ltd-bgne-ceo-john-oyler-sold-144-m | StockLearner2011 | investorshub | 03/22/2018 10:51:09 AM |
https://stocknewstimes.com/2018/03/21/beigene-ltd-bgne-cfo-howard-liang-sells-10 | StockLearner2011 | investorshub | 03/21/2018 5:15:40 PM |
https://finviz.com/quote.ashx?t=Bgne The chart looks traight shooting up! | StockLearner2011 | investorshub | 03/21/2018 3:23:25 PM |
Strong buy! | StockLearner2011 | investorshub | 03/21/2018 12:08:45 PM |
Hot stock. It's looking strong! | StockLearner2011 | investorshub | 03/20/2018 3:34:57 PM |
BeiGene Announces Approval of REVLIMID for Newly Diagnosed | SweepsMcGee | investorshub | 02/27/2018 11:28:18 PM |
$BGNE: New message board for a Chinese biotech | north40000 | investorshub | 02/25/2018 9:18:39 PM |
News, Short Squeeze, Breakout and More Instantly...
BeiGene Ltd. Company Name:
BGNE Stock Symbol:
NASDAQ Market:
With the earnings season in full swing, these large-cap stocks were the best performers in the last week. Are they in your portfolio? Vertiv Holdi...
Newly released report details Company’s achievements and plans for sustainable growth BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, released its 2023 Responsible Business & Sustainability Report highlighting the Company’s strategy, ...
Multiple presentations to showcase the efficacy and safety of BRUKINSA ® across a range of B-cell malignancies Company to present three-year data from RATIONALE-306 study of TEVIMBRA ® in advanced or metastatic esophageal squamous cell carcinoma (ESCC) Be...